The Delaware Supreme Court ruled in favor of companies including GSK (NYSE:GSK), Pfizer (NYSE:PFE), and Boehringer Ingelheim on Thursday, rejecting the legitimacy of expert testimony that linked tens ...

Pfizer (PFE) and BioNTech (BNTX) challenge Moderna's patent win in London court over mRNA COVID-19 vaccine technology. Read ...

Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...

Freshfields has won a Düsseldorf regional court patent dispute on behalf of client Moderna against German COVID-19 vaccine inventors BioNTech and Pfizer. BioNTech, represented by Taylor Wessing ...

Freshfields has won a Düsseldorf regional court patent dispute on behalf of client Moderna against German COVID-19 vaccine inventors BioNTech and Pfizer. BioNTech, represented by Taylor Wessing ...

Pfizer and BioNTech have convinced a U.S. Patent Office tribunal that two patents Moderna accused Pfizer-BioNtech of infringing were invalid. The companies have secured a victory in a round in their ...

As part of a global web of patent litigation over COVID-19 vaccines and mRNA technology, Pfizer and its partner BioNTech traded blows this week with rival Moderna as dueling decisions came down in ...

Pfizer and BioNTech exercised legal authorization to use their patent until May 2023. The court made a decision that Moderna legally withdrew their consent in March 2022 so their previous patent ...

A legal battle between Pfizer and BioNTech and Moderna over vaccine technology patents has produced a mixed ruling from a High Court judge.

Moderna said Friday that the European Patent Office has upheld the validity of one of its key patents, a victory in a continuing dispute with Pfizer and BioNTech over rival COVID-19 vaccines.

Moderna wins a crucial legal battle at the European Patent Office against Pfizer and BioNTech over Covid-19 vaccine patents.

(Reuters) -Moderna has won a case at the European Patent Office in its dispute with Pfizer and BioNTech over its COVID-19 vaccine, the company said on Friday. "We are pleased to announce that the ...